Daniela Morales-Espinosa

Daniela Morales-Espinosa

UNVERIFIED PROFILE

Are you Daniela Morales-Espinosa?   Register this Author

Register author
Daniela Morales-Espinosa

Daniela Morales-Espinosa

Publications by authors named "Daniela Morales-Espinosa"

Are you Daniela Morales-Espinosa?   Register this Author

26Publications

1124Reads

35Profile Views

Liquid Biopsy in Non-Small Cell Lung Cancer.

Front Med (Lausanne) 2016 23;3:69. Epub 2016 Dec 23.

Instituto Oncológico Dr Rosell, Quirón Dexeus University Hospital, Barcelona, Spain; Cancer Biology and Precision Medicine Program, Catalan Institute of Oncology, Germans Trias i Pujol Health Sciences Institute and Hospital, Badalona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3389/fmed.2016.00069DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5179978PMC
December 2016

mutations in the circulating free DNA (cfDNA) of non-small cell lung cancer (NSCLC) patients.

Transl Lung Cancer Res 2016 Oct;5(5):511-516

Pangaea Biotech, Laboratory of Oncology, Quirón Dexeus University Hospital, 08028 Barcelona, Spain;; Dr Rosell Oncology Institute, Quirón Dexeus University Hospital, 08028 Barcelona, Spain;; Cancer Biology & Precision Medicine Program, Catalan Institute of Oncology, Germans Trias i Pujol Health Sciences Institute and Hospital, Crta de Canyet s/n, 08016 Badalona, Spain;; Autonomous University of Barcelona (UAB), Campus Can Ruti, Crta de Canyet s/n, 08016 Badalona, Spain;; Molecular Oncology Research (MORe) Foundation, 08028 Barcelona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.21037/tlcr.2016.10.14DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5099515PMC
October 2016

Fusion gene and splice variant analyses in liquid biopsies of lung cancer patients.

Transl Lung Cancer Res 2016 Oct;5(5):525-531

Pangaea Biotech, Laboratory of Oncology, Quirón Dexeus University Hospital, Barcelona, Spain;; Dr Rosell Oncology Institute, Quirón Dexeus University Hospital, Barcelona, Spain;; Cancer Biology & Precision Medicine Program, Catalan Institute of Oncology, Germans Trias i Pujol Health Sciences Institute and Hospital, Badalona, Spain;; Autonomous University of Barcelona (UAB), Campus Can Ruti, Badalona, Spain;; Molecular Oncology Research (MORe) Foundation, Barcelona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.21037/tlcr.2016.09.02DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5099519PMC
October 2016

Usefulness of circulating free DNA for monitoring epidermal growth factor receptor mutations in advanced non-small cell lung cancer patients: a case report.

Transl Lung Cancer Res 2016 Oct;5(5):532-537

Pangaea Biotech, Medical Oncology Laboratory, Dexeus University Hospital, Quirónsalud Group, Barcelona, Spain;; Translational Cancer Research Unit, Instituto Oncológico Dr Rosell, Dexeus University Hospital-Quirónsalud Group, Barcelona, Spain;; Cancer Biology and Precision Medicine Program, Catalan Institute of Oncology, Germans Triasi Pujol Health Sciences Institute and Hospital, Campus Can Ruti, Badalona, Barcelona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.21037/tlcr.2016.10.04DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5099508PMC
October 2016

Pharmacogenomics in the treatment of lung cancer: an update.

Pharmacogenomics 2015 2;16(15):1751-60. Epub 2015 Oct 2.

Translational Research Laboratory, Catalan Institute of Oncology, Hospital Universitari Germans Trias I Pujol, Ctra Canyet s/n, Badalona, 08916 Barcelona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2217/pgs.15.99DOI Listing
July 2016

Treatment for small cell lung cancer, where are we now?-a review.

Transl Lung Cancer Res 2016 Feb;5(1):26-38

1 Fundación Clínica, Médica Sur. Puente de piedra 150, Col Toriello Guerra, 14050 Mexico City, Mexico ; 2 Translational Research Laboratory, Catalan Institute of Oncology, Hospital Germans Trias i Pujol, Badalona, 08916 Barcelona, Spain ; 3 Dr Rosell Oncology Institute, Quirón Dexeus University Hospital, 08028 Barcelona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3978/j.issn.2218-6751.2016.01.13DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4758961PMC
February 2016

Immunotherapy meets targeted therapy: will this team end the war against cancer?

Transl Lung Cancer Res 2015 Dec;4(6):752-5

1 Rosell Oncology Institute, Quirón-Dexeus University Hospital, Barcelona, Spain ; 2 Pangaea Biotech, Barcelona, Spain ; 3 Institut Quimic de Sarriá, Barcelona, Spain ; 4 Institut Catalá d'Oncologia, Badalona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3978/j.issn.2218-6751.2015.12.05DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4700229PMC
December 2015

Melanoma: oncogenic drivers and the immune system.

Ann Transl Med 2015 Oct;3(18):265

1 Instituto Oncológico Dr Rosell, Quiron-Dexeus University Hospital, Barcelona, Spain ; 2 Department of Medical Oncology, University of Verona, Azienda Ospedaliera Universitaria Integrata, Verona, Italy ; 3 Pangaea Biotech, Quirón Dexeus University Institute, Barcelona, Spain ; 4 Catalan Institute of Oncology, Hospital Germans Trias i Pujol, Badalona, Spain ; 5 Medical Oncology Unit, Human Pathology Department, University of Messina, Messina 98122, Italy ; 6 Instituto Oncológico de Córdoba, Córdoba, Argentina ; 7 Molecular Oncology Research (MORe) Foundation, Barcelona, Spain ; 8 Germans Trias i Pujol Health Sciences Institute and Hospital, Campus Can Ruti, Barcelona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3978/j.issn.2305-5839.2015.08.06DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4630557PMC
October 2015

Erratum to Assays for predicting and monitoring responses to lung cancer immunotherapy.

Cancer Biol Med 2015 Sep;12(3):259

1 Pangaea Biotech, Quirón Dexeus University Hospital, Barcelona 08028, Spain ; 2 Dr. Rosell Oncology Institute, Quirón Dexeus University Hospital, Barcelona 08028, Spain ; 3 Cancer Biology and Precision Medicine Program, Catalan Institute of Oncology, Hospital Germans Trias i Pujol, Badalona 08916, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.7497/j.issn.2095-3941.2015.0055DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4607823PMC
September 2015

Targeting PD-1/PD-L1 in lung cancer: current perspectives.

Lung Cancer (Auckl) 2015 31;6:55-70. Epub 2015 Jul 31.

Translational Cancer Research Unit, Instituto Oncológico Dr Rosell, Quirón Dexeus University Hospital, Barcelona, Spain; Pangaea Biotech SL, Barcelona, Spain; Cancer Biology and Precision Medicine Program, Catalan Institute of Oncology, Germans Trias i Pujol Health Sciences Institute and Hospital, Campus Can Ruti, Badalona, Barcelona, Spain; Fundación Molecular Oncology Research, Barcelona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2147/LCTT.S55176DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5217517PMC
July 2015

Understanding the function and dysfunction of the immune system in lung cancer: the role of immune checkpoints.

Cancer Biol Med 2015 Jun;12(2):79-86

1 Instituto Oncológico Dr Rosell, Quiron Dexeus University Hospital, Barcelona 08028, Spain ; 2 Pangaea Biotech, Barcelona 08028, Spain ; 3 Medical Oncology Unit, Human Pathology Department, University of Messina, Messina 98122, Italy ; 4 Catalan Institute of Oncology, Hospital Germans Trias i Pujol, Badalona 08916, Spain ; 5 Molecular Oncology Research (MORe) Foundation, Barcelona 08028, Spain ; 6 Germans Trias i Pujol Health Sciences Institute and Hospital, Campus Can Ruti 08916, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.7497/j.issn.2095-3941.2015.0029DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4493378PMC
June 2015

Assays for predicting and monitoring responses to lung cancer immunotherapy.

Cancer Biol Med 2015 Jun;12(2):87-95

1 Pangaea Biotech, Quirón Dexeus University Hospital, Barcelona 08028, Spain ; 2 Dr. Rosell Oncology Institute, Quirón Dexeus University Hospital, Barcelona 08028, Spain ; 3 Cancer Biology and Precision Medicine Program, Catalan Institute of Oncology, Hospital Germans Trias i Pujol, Badalona 08916, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.7497/j.issn.2095-3941.2015.0019DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4493376PMC
June 2015

Second-line treatment in EGFR-unselected patients: is it time to close one arm of this river's DELTA?

J Thorac Dis 2015 Mar;7(3):227-9

1 Translational Research Laboratoryatalan Institute of Oncology, Hospital Germans Trias i Pujol, 08916 Barcelona, Badalona, Spain ; 2 Fundación Clínica, Médica Sur. Puente de piedra 150, Col Toriello Guerra, 14050 Mexico City, Mexico ; 3 Carcinogenesis laboratory, National Cancer Institute, Col. Sección XVI, 14080 Mexico City, México ; 4 Cancer Biology & Precision Medicine Program, Catalan Institute of Oncology, Germans Trias i Pujol Health Sciences Institute and Hospital, Campus Can Ruti, 08916 Badalona, Barcelona, Spain ; 5 Molecular Oncology Research (MORe) Foundation, C/Sabino Arana 5-19, 08028 Barcelona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3978/j.issn.2072-1439.2015.01.34DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4387398PMC
March 2015

Systemic treatment in EGFR-ALK NSCLC patients: second line therapy and beyond.

Expert Rev Anticancer Ther 2014 Jul 10;14(7):807-15. Epub 2014 Mar 10.

Instituto Oncológico Dr Rosell, Quirón-Dexeus Hospital Universitario, Barcelona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1586/14737140.2014.896210DOI Listing
July 2014

Worldwide mortality from cirrhosis.

Ann Hepatol 2007 Jul-Sep;6(3):194-5

Department of Biomedical Research and Liver Unit, Medica Sur Clinic and Foundation, Mexico City, Mexico.

View Article

Download full-text PDF

Source
November 2007

Response of negative estrogen-receptor hepatocarcinoma to tamoxifen, and survival of non-resectable patients.

Ann Hepatol 2006 Oct-Dec;5(4):263-7

Department of Medical Gastroenterology, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, México.

View Article

Download full-text PDF

Source
February 2007

Clinico-pathological and immunohistochemical characteristics associated to recurrence/regrowth of craniopharyngiomas.

Clin Neurol Neurosurg 2006 Oct 24;108(7):661-9. Epub 2006 Feb 24.

Department of Neuropathology, Instituto Nacional de Neurología y Neurocirugía, Mexico.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clineuro.2006.01.007DOI Listing
October 2006

Prolonged exposure to lead lowers the threshold of pentylenetetrazole-induced seizures in rats.

Epilepsia 2005 Oct;46(10):1599-602

Neuroimmunology Unit, Instituto Nacional de Neurología y Neurocirugía, Mexico City, Mexico.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1528-1167.2005.00267.xDOI Listing
October 2005